MSP Recovery

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MSP Recovery and buy or sell other stocks, ETFs, and their options commission-free!

About MSPR

MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. 

CEO
John H. Ruiz
CEOJohn H. Ruiz
Employees
78
Employees78
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2014
Founded2014
Employees
78
Employees78

MSPR Key Statistics

Market cap
984.40
Market cap984.40
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
444.87K
Average volume444.87K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.06
52 Week high$6.06
52 Week low
$0.392
52 Week low$0.392

Stock Snapshot

As of today, MSP Recovery(MSPR) shares are valued at $0.00. The company's market cap stands at 984.4, with a P/E ratio of -0.01.

MSP Recovery(MSPR) stock opened on 2026-08-22 at —. The price climbed to — and dipped to —.

MSP Recovery(MSPR) shares are trading with a volume of 0, against a daily average of 444.87K.

In the last year, MSP Recovery(MSPR) shares hit a 52-week high of $6.06 and a 52-week low of $0.39.

In the last year, MSP Recovery(MSPR) shares hit a 52-week high of $6.06 and a 52-week low of $0.39.

People also own

Based on the portfolios of people who own MSPR. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.